Multicenter Study on COVID-19 Lung Computed Tomography Segmentation with varying Glass Ground Opacities using Unseen Deep Learning Artificial Intelligence Paradigms: COVLIAS 1.0 Validation.

Journal: Journal of medical systems
Published Date:

Abstract

Variations in COVID-19 lesions such as glass ground opacities (GGO), consolidations, and crazy paving can compromise the ability of solo-deep learning (SDL) or hybrid-deep learning (HDL) artificial intelligence (AI) models in predicting automated COVID-19 lung segmentation in Computed Tomography (CT) from unseen data leading to poor clinical manifestations. As the first study of its kind, "COVLIAS 1.0-Unseen" proves two hypotheses, (i) contrast adjustment is vital for AI, and (ii) HDL is superior to SDL. In a multicenter study, 10,000 CT slices were collected from 72 Italian (ITA) patients with low-GGO, and 80 Croatian (CRO) patients with high-GGO. Hounsfield Units (HU) were automatically adjusted to train the AI models and predict from test data, leading to four combinations-two Unseen sets: (i) train-CRO:test-ITA, (ii) train-ITA:test-CRO, and two Seen sets: (iii) train-CRO:test-CRO, (iv) train-ITA:test-ITA. COVILAS used three SDL models: PSPNet, SegNet, UNet and six HDL models: VGG-PSPNet, VGG-SegNet, VGG-UNet, ResNet-PSPNet, ResNet-SegNet, and ResNet-UNet. Two trained, blinded senior radiologists conducted ground truth annotations. Five types of performance metrics were used to validate COVLIAS 1.0-Unseen which was further benchmarked against MedSeg, an open-source web-based system. After HU adjustment for DS and JI, HDL (Unseen AI) > SDL (Unseen AI) by 4% and 5%, respectively. For CC, HDL (Unseen AI) > SDL (Unseen AI) by 6%. The COVLIAS-MedSeg difference was < 5%, meeting regulatory guidelines.Unseen AI was successfully demonstrated using automated HU adjustment. HDL was found to be superior to SDL.

Authors

  • Jasjit S Suri
    Advanced Knowledge Engineering Center, Global Biomedical Technologies, Inc., Roseville, CA, USA. Electronic address: jsuri@comcast.net.
  • Sushant Agarwal
    Advanced Knowledge Engineering Centre, GBTI, Roseville, CA, USA; Department of Computer Science Engineering, PSIT, Kanpur, India.
  • Luca Saba
    Department of Radiology, A.O.U., Italy.
  • Gian Luca Chabert
    Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), Cagliari, Italy.
  • Alessandro Carriero
  • Alessio Paschè
    Department of Radiology, A.O.U, "Maggiore d.c." Universiy of Eastern Piedmont, Novara, Italy.
  • Pietro Danna
    Department of Radiology, A.O.U, "Maggiore d.c." Universiy of Eastern Piedmont, Novara, Italy.
  • Armin Mehmedovic
    University Hospital for Infectious Diseases, Zagreb, Croatia.
  • Gavino Faa
    Department of Pathology, 09100, AOU of Cagliari, Italy.
  • Tanay Jujaray
    Vista Del Lago, Folsom, CA, USA.
  • Inder M Singh
    Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA.
  • Narendra N Khanna
    Cardiology Department, Apollo Hospitals, New Delhi, India.
  • John R Laird
    UC Davis Vascular Center, University of California, Davis, CA, USA.
  • Petros P Sfikakis
    1st Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Vikas Agarwal
    Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
  • Jagjit S Teji
    Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, USA.
  • Rajanikant R Yadav
    SGPIMS, Uttar Pradesh, Lucknow, India.
  • Ferenc Nagy
    Institute of Plant Biology, Biological Research Centre of the Hungarian Academy of Sciences, H-6726 Szeged, Hungary.
  • Zsigmond Tamás Kincses
    Department of Radiology, University of Szeged, 6725, Hungary.
  • Zoltan Ruzsa
    Department of Internal Medicines, Invasive Cardiology Division, University of Szeged, Szeged, Hungary.
  • Klaudija Viskovic
    University Hospital for Infectious Diseases, 10000, Zagreb, Crotia.
  • Mannudeep K Kalra